According to reports, Mexican President Lopez said on Monday (17) that if Russia’s new crown vaccine proved effective, he would voluntarily become one of the first to vaccinate the vaccine. “I’m going to be the first to get vaccinated,” he said at a regular press conference.
on August 11, Russia registered the world’s first vaccine against new coronavirus, named “Sputnik V”. Its clinical trial was successfully completed from June to July this year. On August 15, the Russian Ministry of Health announced that it had started production of vaccines. According to the Russian drug registry, the drug will be used as a solution for intramuscular injection. The vaccine plan is carried out in two phases: after the first injection, it is injected again every three weeks. According to the Russian Ministry of health, a double injection program can produce immunity for up to two years.
with regard to the research and development of the new crown vaccine in Russia, many countries in the United States and the West have questioned its safety and effectiveness, believing that a certain trial stage may be skipped, and there is no document or data to support the efficacy of the vaccine. Russia refutes this. On the 13th local time, Bruce elwald, senior adviser to the director general of who, said that there was not enough information to make a judgment on Russia’s new coronal vaccine. “We are currently in dialogue with Russia to get more information about the product, the tests that have been carried out and the next steps to be taken.”
at the same time, the global vaccine competition continues. Previously, the governments of Mexico and Argentina have signed a cooperation agreement with the British Pharmaceutical Company AstraZeneca to produce new coronavirus vaccines for Latin American countries except Brazil. According to a previous report, Argentine President Fernandez will produce 150-250 million doses of vaccine for the entire Latin American region outside Brazil on the evening of 12th local time. It is expected that the vaccine will be delivered in the first half of 2021. Argentina and Mexico will be responsible for the production and distribution of vaccines, which will be equally distributed according to the needs of each country and regional government. Fernandez added that the price of each dose ranged from $3 to $4, which was significant for Latin America. Currently, the candidate vaccine of AstraZeneca is undergoing phase 3 clinical trial, and the results will be published in November. The novel coronavirus pneumonia in Mexico has exceeded 520 thousand, and the number of deaths has exceeded 56 thousand, according to
‘s statistics. According to the statistics of Worldometer website, the epidemic situation is grim.